1637.0000 -9.60 (-0.58%)
NSE May 21, 2026 15:31 PM
Volume: 220.5K
 

1637.00
-0.58%
Motilal Oswal
After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.
Ipca Laboratories Ltd. is trading above all available SMAs
More from Ipca Laboratories Ltd.
Recommended